|
|
|
|
|
|
|
|
CONCLUSIONS: This combination was well tolerated and appears more active than the historical control of single agent taxane therapy in those with recurrent ovarian and peritoneal cancer after failing multiple lines of chemotherapy. Further study is warranted
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.